Logo image of ACCS

ACCESS NEWSWIRE INC (ACCS) Stock Fundamental Analysis

NYSEARCA:ACCS - US46520M2044 - Common Stock

11 USD
+0.4 (+3.77%)
Last: 8/29/2025, 8:05:12 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to ACCS. ACCS was compared to 280 industry peers in the Software industry. Both the profitability and financial health of ACCS have multiple concerns. ACCS has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

ACCS had positive earnings in the past year.
ACCS had a positive operating cash flow in the past year.
ACCS had positive earnings in 4 of the past 5 years.
In the past 5 years ACCS always reported a positive cash flow from operatings.
ACCS Yearly Net Income VS EBIT VS OCF VS FCFACCS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M

1.2 Ratios

ACCS has a Return On Assets of -11.14%. This is in the lower half of the industry: ACCS underperforms 63.57% of its industry peers.
ACCS has a Return On Equity of -17.05%. This is comparable to the rest of the industry: ACCS outperforms 43.21% of its industry peers.
Industry RankSector Rank
ROA -11.14%
ROE -17.05%
ROIC N/A
ROA(3y)-5.74%
ROA(5y)-0.56%
ROE(3y)-11.6%
ROE(5y)-3.38%
ROIC(3y)N/A
ROIC(5y)N/A
ACCS Yearly ROA, ROE, ROICACCS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30 -40

1.3 Margins

The Gross Margin of ACCS (77.19%) is better than 74.29% of its industry peers.
In the last couple of years the Gross Margin of ACCS has grown nicely.
The Profit Margin and Operating Margin are not available for ACCS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 77.19%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.85%
GM growth 5Y1.91%
ACCS Yearly Profit, Operating, Gross MarginsACCS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

3

2. Health

2.1 Basic Checks

ACCS does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ACCS has more shares outstanding
ACCS has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ACCS has a worse debt to assets ratio.
ACCS Yearly Shares OutstandingACCS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M
ACCS Yearly Total Debt VS Total AssetsACCS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

ACCS has an Altman-Z score of 1.93. This is not the best score and indicates that ACCS is in the grey zone with still only limited risk for bankruptcy at the moment.
ACCS has a Altman-Z score (1.93) which is in line with its industry peers.
The Debt to FCF ratio of ACCS is 1.26, which is an excellent value as it means it would take ACCS, only 1.26 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 1.26, ACCS is doing good in the industry, outperforming 72.14% of the companies in the same industry.
ACCS has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
ACCS has a Debt to Equity ratio (0.10) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 1.26
Altman-Z 1.93
ROIC/WACCN/A
WACC11.4%
ACCS Yearly LT Debt VS Equity VS FCFACCS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.3 Liquidity

A Current Ratio of 0.75 indicates that ACCS may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.75, ACCS is doing worse than 82.86% of the companies in the same industry.
ACCS has a Quick Ratio of 0.75. This is a bad value and indicates that ACCS is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.75, ACCS is doing worse than 82.86% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.75
Quick Ratio 0.75
ACCS Yearly Current Assets VS Current LiabilitesACCS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

3

3. Growth

3.1 Past

ACCS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -20.83%.
The Earnings Per Share has been growing by 9.60% on average over the past years. This is quite good.
ACCS shows a decrease in Revenue. In the last year, the revenue decreased by -5.97%.
The Revenue has been growing slightly by 7.19% on average over the past years.
EPS 1Y (TTM)-20.83%
EPS 3Y-10.86%
EPS 5Y9.6%
EPS Q2Q%-36.36%
Revenue 1Y (TTM)-5.97%
Revenue growth 3Y1.76%
Revenue growth 5Y7.19%
Sales Q2Q%-26.88%

3.2 Future

ACCS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.54% yearly.
Based on estimates for the next years, ACCS will show a decrease in Revenue. The Revenue will decrease by -6.75% on average per year.
EPS Next Y-28.75%
EPS Next 2Y9.54%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-21.97%
Revenue Next 2Y-6.75%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ACCS Yearly Revenue VS EstimatesACCS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M
ACCS Yearly EPS VS EstimatesACCS Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1

5

4. Valuation

4.1 Price/Earnings Ratio

ACCS is valuated rather expensively with a Price/Earnings ratio of 19.30.
Based on the Price/Earnings ratio, ACCS is valued a bit cheaper than 78.57% of the companies in the same industry.
ACCS's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.13.
ACCS is valuated correctly with a Price/Forward Earnings ratio of 13.48.
Based on the Price/Forward Earnings ratio, ACCS is valued cheaply inside the industry as 87.50% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.76, ACCS is valued a bit cheaper.
Industry RankSector Rank
PE 19.3
Fwd PE 13.48
ACCS Price Earnings VS Forward Price EarningsACCS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as ACCS.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ACCS indicates a rather cheap valuation: ACCS is cheaper than 86.79% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 16.82
EV/EBITDA 384.87
ACCS Per share dataACCS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)2.01
EPS Next 2Y9.54%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ACCS!.
Industry RankSector Rank
Dividend Yield N/A

ACCESS NEWSWIRE INC

NYSEARCA:ACCS (8/29/2025, 8:05:12 PM)

11

+0.4 (+3.77%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-12 2025-08-12/bmo
Earnings (Next)11-05 2025-11-05
Inst Owners41.8%
Inst Owner ChangeN/A
Ins Owners22.46%
Ins Owner Change2.79%
Market Cap42.57M
Analysts82.5
Price Target13.77 (25.18%)
Short Float %0.08%
Short Ratio0.18
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-36.39%
Min EPS beat(2)-62.29%
Max EPS beat(2)-10.49%
EPS beat(4)1
Avg EPS beat(4)-21.68%
Min EPS beat(4)-62.29%
Max EPS beat(4)2.71%
EPS beat(8)2
Avg EPS beat(8)-25.47%
EPS beat(12)4
Avg EPS beat(12)-18.9%
EPS beat(16)6
Avg EPS beat(16)-9.39%
Revenue beat(2)0
Avg Revenue beat(2)-15.89%
Min Revenue beat(2)-22.56%
Max Revenue beat(2)-9.23%
Revenue beat(4)0
Avg Revenue beat(4)-9.35%
Min Revenue beat(4)-22.56%
Max Revenue beat(4)-1.08%
Revenue beat(8)0
Avg Revenue beat(8)-11.65%
Revenue beat(12)1
Avg Revenue beat(12)-9.09%
Revenue beat(16)3
Avg Revenue beat(16)-6.54%
PT rev (1m)-10%
PT rev (3m)3.85%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-54.05%
EPS NY rev (1m)-32.14%
EPS NY rev (3m)-32.14%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.51%
Revenue NY rev (1m)-2.94%
Revenue NY rev (3m)-7.1%
Valuation
Industry RankSector Rank
PE 19.3
Fwd PE 13.48
P/S 1.97
P/FCF 16.82
P/OCF 14.57
P/B 1.38
P/tB N/A
EV/EBITDA 384.87
EPS(TTM)0.57
EY5.18%
EPS(NY)0.82
Fwd EY7.42%
FCF(TTM)0.65
FCFY5.95%
OCF(TTM)0.75
OCFY6.86%
SpS5.57
BVpS7.98
TBVpS-0.1
PEG (NY)N/A
PEG (5Y)2.01
Profitability
Industry RankSector Rank
ROA -11.14%
ROE -17.05%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 77.19%
FCFM 11.73%
ROA(3y)-5.74%
ROA(5y)-0.56%
ROE(3y)-11.6%
ROE(5y)-3.38%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.85%
GM growth 5Y1.91%
F-Score4
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 1.26
Debt/EBITDA 30.15
Cap/Depr 13.45%
Cap/Sales 1.81%
Interest Coverage N/A
Cash Conversion 2755.66%
Profit Quality N/A
Current Ratio 0.75
Quick Ratio 0.75
Altman-Z 1.93
F-Score4
WACC11.4%
ROIC/WACCN/A
Cap/Depr(3y)14.81%
Cap/Depr(5y)14.14%
Cap/Sales(3y)1.67%
Cap/Sales(5y)1.28%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-20.83%
EPS 3Y-10.86%
EPS 5Y9.6%
EPS Q2Q%-36.36%
EPS Next Y-28.75%
EPS Next 2Y9.54%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.97%
Revenue growth 3Y1.76%
Revenue growth 5Y7.19%
Sales Q2Q%-26.88%
Revenue Next Year-21.97%
Revenue Next 2Y-6.75%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-227.99%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year244.06%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-31.46%
FCF growth 3Y-17.03%
FCF growth 5Y0.97%
OCF growth 1Y-21.96%
OCF growth 3Y-12.59%
OCF growth 5Y1.99%